Animals (2020) 10:342
For individuals with a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, or other Asian family origin, or Black African or African-Caribbean family origin) and at least one weight-related comorbidity, GLP-1 receptor agonists such as semaglutide (Wegovy) may be considered through specialist weight management services, subject to the specific criteria and treatment duration outlined in the relevant NICE technology appraisal
The levels of semaglutide will steadily increase in the bloodstream and travel to the target organs, such as the brain
Sign up for our newsletter Events, news and information not just for students but for the industry as a whole
Asked a few weeks ago by this newspaper about the medications approximate launch date in Spain, Francisco Pajuelo, Novo Nordisks medical director in Spain, declined to specify a date and commented that the drug shortages will continue throughout 2023. Sign up for our weekly newsletter to get more English-language news coverage from EL PAS USA Edition
This is the reason why the fundamental criteria for injectable B12the route of administration and the severity of the underlying conditionhave not changed
